Larvol Delta - DFBTJY09DM301-A-Phase-3-Study-to-Evaluate-the-Efficacy-of-JY09-Compared-With-Placebo-in-T2DM-Patients

Byetta (exenatide) - AstraZeneca

JY09 - Beijing Dongfang Biotech

http://clinicaltrials.gov/ct2/show/NCT06254014

Aug 20, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next